Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ono, Makiko"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
    Autorzy:
    Tan RSYC; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore.
    Ong WS; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.
    Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
    Lim AH; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.
    Park S; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of South Korea.
    Park YH; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of South Korea.; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of South Korea.
    Lin CH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
    Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
    Ono M; Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
    Ueno T; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
    Naito Y; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
    Onishi T; Department of Breast Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
    Lim GH; Breast Department, KK Women's and Children's Hospital, Singapore, Singapore.; Sing Health Duke-NUS Breast Centre, Singapore, Singapore.
    Tan SM; Sing Health Duke-NUS Breast Centre, Singapore, Singapore.; Division of Breast Surgery, Department of General Surgery, Changi General Hospital, Singapore, Singapore.
    Lee HB; Department of Surgery, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
    Ryu HS; Department of Pathology, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
    Han W; Department of Surgery, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
    Tan VKM; Sing Health Duke-NUS Breast Centre, Singapore, Singapore.; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.
    Wong FY; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
    Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
    Tan PH; Division of Pathology, Singapore General Hospital, Singapore, Singapore.
    Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore.; Cancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.
    Yap YS; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore. .; Duke-NUS Medical School, Singapore, Singapore. .
    Pokaż więcej
    Źródło:
    BMC medicine [BMC Med] 2022 Mar 17; Vol. 20 (1), pp. 105. Date of Electronic Publication: 2022 Mar 17.
    Typ publikacji:
    Journal Article; Multicenter Study
    MeSH Terms:
    Breast Neoplasms*/pathology
    DNA Copy Number Variations*/genetics
    Cohort Studies ; Female ; Humans ; Neoplasm Recurrence, Local ; Prognosis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The expression and clinical significance of ribophorin II (RPN2) in human breast cancer.
    Autorzy:
    Ono M; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
    Tsuda H; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.; Department of Basic Pathology, National Defense Medical College, Saitama, Japan.
    Kobayashi T; Department of Basic Pathology, National Defense Medical College, Saitama, Japan.
    Takeshita F; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
    Takahashi RU; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
    Tamura K; Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
    Akashi-Tanaka S; Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
    Moriya T; Department of Surgery, National Defense Medical College, Saitama, Japan.
    Yamasaki T; Department of Surgery, National Defense Medical College, Saitama, Japan.
    Kinoshita T; Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
    Yamamoto J; Department of Surgery, National Defense Medical College, Saitama, Japan.
    Fujiwara Y; Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
    Ochiya T; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    Pathology international [Pathol Int] 2015 Jun; Vol. 65 (6), pp. 301-8. Date of Electronic Publication: 2015 Apr 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*pathology
    Hexosyltransferases/*metabolism
    Proteasome Endopeptidase Complex/*metabolism
    Tumor Suppressor Protein p53/*metabolism
    Breast Neoplasms/metabolism ; Breast Neoplasms/surgery ; Breast Neoplasms, Male/metabolism ; Breast Neoplasms, Male/pathology ; Breast Neoplasms, Male/surgery ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Tissue Array Analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies